Lower cerebral blood flow is associated with faster cognitive decline in Alzheimer's disease
- PMID: 27334014
- PMCID: PMC5306323
- DOI: 10.1007/s00330-016-4450-z
Lower cerebral blood flow is associated with faster cognitive decline in Alzheimer's disease
Abstract
Objective: To determine whether lower cerebral blood flow (CBF) is associated with faster cognitive decline in patients with Alzheimer's disease (AD).
Methods: We included 88 patients with dementia due to AD from the Amsterdam Dementia Cohort. Mean follow-up was 2 ± 1 years. Linear mixed models were used to determine associations of lower whole brain and regional pseudo-continuous arterial spin labelling measured CBF with rate of cognitive decline as measured with repeated mini-mental state examination (MMSE). Model 1 was adjusted for age, sex, and education. Model 2 was additionally adjusted for normalized gray matter volume, medial temporal lobe atrophy, white matter hyperintensities, microbleeds, and lacunes. Analyses were repeated after partial volume correction (PVC) of CBF. Statistical significance was set at p ≤ 0.05.
Results: Patients were 65 ± 7 years old, 44 (50 %) were women, and mean baseline MMSE was 22 ± 4. Annual decline (β[SE]) on the MMSE was estimated at -2.11 (0.25) points per year. Lower whole brain (β[SE]-0.50[0.25]; p ≤ 0.05) and parietal (β[SE]-0.59[0.25]; p < 0.05) CBF were associated with faster cognitive decline. PVC cortical CBF was not associated with cognitive decline.
Conclusions: Lower CBF, in particular in the posterior brain regions, may have value as a prognostic marker for rate of cognitive decline in AD.
Key points: • In AD, lower CBF is associated with more rapid cognitive decline. • Decreasing CBF does not reach a plateau early in AD. • PcASL-CFB has additive value to conventional structural MRI measures in AD.
Keywords: Alzheimer’s disease; dementia; perfusion; prognosis; progression.
Similar articles
-
The Neuropsychological Correlates of Brain Perfusion and Gray Matter Volume in Alzheimer's Disease.J Alzheimers Dis. 2020;78(4):1639-1652. doi: 10.3233/JAD-200676. J Alzheimers Dis. 2020. PMID: 33185599
-
Modeling grey matter atrophy as a function of time, aging or cognitive decline show different anatomical patterns in Alzheimer's disease.Neuroimage Clin. 2019;22:101786. doi: 10.1016/j.nicl.2019.101786. Epub 2019 Mar 19. Neuroimage Clin. 2019. PMID: 30921610 Free PMC article.
-
Temporal gradient during famous face naming is associated with lower cerebral blood flow and gray matter volume in aging.Neuropsychologia. 2017 Dec;107:76-83. doi: 10.1016/j.neuropsychologia.2017.11.011. Epub 2017 Nov 10. Neuropsychologia. 2017. PMID: 29133109 Free PMC article.
-
Altered cerebral perfusion in bipolar disorder: A pCASL MRI study.Bipolar Disord. 2021 Mar;23(2):130-140. doi: 10.1111/bdi.12966. Epub 2020 Jul 25. Bipolar Disord. 2021. PMID: 32583570 Review.
-
Cerebral blood flow measured by arterial spin labeling MRI as a preclinical marker of Alzheimer's disease.J Alzheimers Dis. 2014;42 Suppl 4(Suppl 4):S411-9. doi: 10.3233/JAD-141467. J Alzheimers Dis. 2014. PMID: 25159672 Free PMC article. Review.
Cited by
-
Arterial spin labeling for the measurement of cerebral perfusion and angiography.J Cereb Blood Flow Metab. 2018 Apr;38(4):603-626. doi: 10.1177/0271678X17743240. Epub 2017 Nov 23. J Cereb Blood Flow Metab. 2018. PMID: 29168667 Free PMC article. Review.
-
Effects of Low-Level Blast on Neurovascular Health and Cerebral Blood Flow: Current Findings and Future Opportunities in Neuroimaging.Int J Mol Sci. 2024 Jan 4;25(1):642. doi: 10.3390/ijms25010642. Int J Mol Sci. 2024. PMID: 38203813 Free PMC article. Review.
-
Therapeutic non-invasive brain treatments in Alzheimer's disease: recent advances and challenges.Inflamm Regen. 2022 Oct 3;42(1):31. doi: 10.1186/s41232-022-00216-8. Inflamm Regen. 2022. PMID: 36184623 Free PMC article. Review.
-
The effect of physical exercise on cerebral blood flow in Alzheimer's disease.Neuroimage Clin. 2018 Sep 4;20:650-654. doi: 10.1016/j.nicl.2018.09.003. eCollection 2018. Neuroimage Clin. 2018. PMID: 30211001 Free PMC article. Clinical Trial.
-
Cerebrovascular alterations in a mouse model of late-onset Alzheimer's disease.Neurophotonics. 2025 Jan;12(Suppl 1):S14614. doi: 10.1117/1.NPh.12.S1.S14614. Epub 2025 Jun 5. Neurophotonics. 2025. PMID: 40475700 Free PMC article.
References
-
- Doody RS, Massman P, Dunn JK. A method for estimating progression rates in Alzheimer disease. Arch Neurol. 2001;58:449–454. - PubMed
-
- Sperling RA, Aisen PS, Beckett LA, et al. Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011;7:280–292. doi: 10.1016/j.jalz.2011.03.003. - DOI - PMC - PubMed
-
- Scheltens P, Blennow K, Breteler MM et al (2016) Alzheimer’s disease. Lancet. doi: 10.1016/S0140-6736(15)01124-1
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous